WINDTREE THERAPEUTICS INC /DE/

WINDTREE THERAPEUTICS INC /DE/ insiders are currently net buyers of WINT stock, showing bullish sentiment over the past 90 days. Executives have purchased $68.8M while selling $2.0M, resulting in a positive net flow of $66.8M. This buying activity represents 97% of total transaction volume.

WINDTREE THERAPEUTICS INC /DE/ has 21 active insiders who have filed SEC Form 4 transactions in the past 90 days. Pharmaceutical Holdings Ltd Lee's (Executive) leads with 5 transactions totaling $47.1M. II Investments Ltd Lph (Executive) follows with 2 transactions worth $11.0M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. WINDTREE THERAPEUTICS INC /DE/'s current score of 97/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $68.8M in purchases versus $2.0M in sales.

The most recent insider transaction occurred on Jul 22, 2024, when Fraser Craig (Executive) acquired 4,011 shares at $0.00 per share for $0. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, WINT insider trading sentiment is currently bullish with an Alignment Score of 97/100. The net insider flow of $66.8M reflects accumulation, with 97% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like WINDTREE THERAPEUTICS INC /DE/. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At WINT, we track all Form 4 filings—currently showing 141 transactions from 21 insiders over 90 days.

A 10b5-1 plan allows WINDTREE THERAPEUTICS INC /DE/ executives to pre-schedule stock sales when they don't possess material non-public information. At WINT, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at WINT appears discretionary, making insider signals more meaningful.

You can monitor WINDTREE THERAPEUTICS INC /DE/ (WINT) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 21 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. WINDTREE THERAPEUTICS INC /DE/'s current score of 97/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $68.8M in purchases versus $2.0M in sales over 90 days, resulting in a net flow of $66.8M.

SEC Form 4 filings are mandatory reports that WINDTREE THERAPEUTICS INC /DE/ insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At WINT, the most common type is "P" with 24 occurrences. The most recent Form 4 was filed on Jul 22, 2024 by Fraser Craig.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At WINDTREE THERAPEUTICS INC /DE/, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at WINT represents discretionary decisions with more informational value.